This patent describes methods for passively regulating flow in microfluidic systems. The techniques are particularly well suited for simple and portable analytical systems — such as those used in point-of-care diagnostics. Actions such as stopping and re-starting flow and controlled reaction and incubation times which would normally require complex instrumentation can be pre-programmed in the design of each microfluidic system. This enables the performance of relatively complex assays with minimal equipment. Bio-analytical procedures such as thermo-cycling for PCR, enzymatic amplification of signals in solution, and timed incubation and mixing can now be implemented in robust, easy-to-use, and cost-effective systems.
"Although this patent was intended to apply to a specific set of assays
currently under development at OPKO, we view this as a particularly
important enabling technology for adapting almost any laboratory test
onto our platform," said
About
OPKO is a multi-national biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.
This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning, including statements regarding the potential benefits of OPKO's diagnostic technology, whether a patent for OPKO's technology will issue based on the notice of allowance, the ability of the technology to enable performance of complex assays with minimal equipment and implement bio-analytical procedures in robust, easy-to-use and cost effective systems, the ability to adapt almost any laboratory test for our platform, our ability to successfully develop tests utilizing the technology and to differentiate our product from those of competitors, and the suitability and ease of use of our product for the point-of care markets, as well as other non-historical statements about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects.
Many factors could cause our actual activities or results to differ
materially from the activities and results anticipated in
forward-looking statements. These factors include those described in our
filings with the
Source:
News Provided by Acquire Media
